A Retrospective analysis to Characterize Arthralgia Induced by PD-1 antibodies treatment in Patients with Metastasized Cutaneous Malignancies.
Latest Information Update: 05 Feb 2019
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
Most Recent Events
- 05 Feb 2019 New trial record